New Zealand markets closed

Metropolitan Bank Holding Corp. (MCB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
44.87+0.64 (+1.44%)
As of 02:47PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 495.06M
Enterprise value N/A
Trailing P/E 7.23
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.96
Price/book (mrq)0.74
Enterprise value/revenue 3.58
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 376.99%
S&P500 52-week change 326.36%
52-week high 357.15
52-week low 324.00
50-day moving average 338.78
200-day moving average 340.90

Share statistics

Avg vol (3-month) 395.69k
Avg vol (10-day) 362.03k
Shares outstanding 511.19M
Implied shares outstanding 611.19M
Float 89.79M
% held by insiders 16.61%
% held by institutions 180.29%
Shares short (30 Apr 2024) 4676.87k
Short ratio (30 Apr 2024) 46.32
Short % of float (30 Apr 2024) 46.47%
Short % of shares outstanding (30 Apr 2024) 46.05%
Shares short (prior month 28 Mar 2024) 4663.72k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 28.52%
Operating margin (ttm)41.11%

Management effectiveness

Return on assets (ttm)0.99%
Return on equity (ttm)10.68%

Income statement

Revenue (ttm)239.78M
Revenue per share (ttm)21.64
Quarterly revenue growth (yoy)2.00%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)68.11M
Diluted EPS (ttm)6.12
Quarterly earnings growth (yoy)-35.40%

Balance sheet

Total cash (mrq)539.45M
Total cash per share (mrq)48.2
Total debt (mrq)429.98M
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)60.18

Cash flow statement

Operating cash flow (ttm)28.39M
Levered free cash flow (ttm)N/A